Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine - Tabular View

Tracking Information

First Received Date ^ICMJE

March 28, 2007

Last Updated Date

September 11, 2009

Start Date ^ICMJE

March 2007

Primary Completion Date

January 2008 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Parent satisfaction on a 11-point scale [ Time Frame: duration of the study ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00453583 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Physician satisfaction on an 11-point scale [ Time Frame: duration of the study ]
Efficacy, tolerability and global satisfaction [ Time Frame: duration of the study ]

Original Secondary Outcome Measures ^ICMJE

Same as current

Descriptive Information

Brief Title ^ICMJE

Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine

Official Title ^ICMJE

Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment

Brief Summary

This is a non-interventional retrospective data collection study from children aged from 2 to 12 years old diagnosed with an allergy and who received a treatment consisting of an H1-antihistamine. The period of last taken medication will be observed to evaluate the global satisfaction of the parents and physician for this last treatment.

Detailed Description

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Other, Retrospective

Condition ^ICMJE

Allergies

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

4581

Completion Date

January 2008

Primary Completion Date

January 2008 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Children from 2-12 included
History of allergy
Used an Antihistamine within market authorization

Exclusion Criteria:

Child not yet treated for the presented allergy

Gender

Both

Ages

2 Years to 12 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00453583

Responsible Party

Study Director, UCB

Study ID Numbers ^ICMJE

A00420

Study Sponsor ^ICMJE

UCB, Inc.

Collaborators ^ICMJE

Investigators ^ICMJE

Study Director:

UCB Clinical Trial Call Center

+1 877 822 9493 (UCB)

Information Provided By

UCB, Inc.

Verification Date

September 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP